P
Last Price
52 Week Range
DKK0.07 - DKK0.19
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | DKK114.65M |
EV | DKK132.40M |
Shares Outstanding | 1.23B |
Beta | 0.83 |
Industry | Biotechnology |
Analyst Rating | - |
Analyst Target Price | - |
Number of Analysts | 0 |
P/E E | - |
P/Revenue E | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin E | - |
Net Profit Margin E | - |
ROE E | - |
ROCE | - |
DPS E | - |
Payout Ratio E | - |
Div. Yield E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
P
Pharma Equity Group A/S
PEG
Sector
Healthcare
Industry
Biotechnology
CEO
Tange, Christian
Employees
Website
www.pharmaequitygroup.comIPO Date
2023-05-16
Headquarters
Slotsmarken 18 2. th., Horsholm, Capital Region of Denmark, 2970, Denmark
The last closing price of Pharma Equity Group (PEG) is DKK0.09, reflecting a -0.21% change from the prior session. Last updated: December 30, 2025 at 11:02 AM Eastern Time
Review the recent PEG stock performance trends:Past 1 Month: Pharma Equity Group (PEG) shares have -20.85%.Past 3 Months: The stock has -10.19%.Past 6 Months: PEG shares have -23.44%. Last updated: December 31, 2025 at 11:43 PM Eastern Time
Over the last year, Pharma Equity Group (PEG) has established a 52-week price range between a high of DKK0.19 and a low of DKK0.07. This metric is essential for assessing the stock's annual volatility. Last updated: December 31, 2025 at 11:43 PM Eastern Time
Pharma Equity Group (PEG) is considered a medium volatility stock. It has a beta of 0.83, which means it typically moves 0.83 times as much as the broader market. Over the past 52 weeks, PEG has traded within a DKK0.07 – DKK0.19 range. Last updated: December 31, 2025 at 11:43 PM Eastern Time
The current Pharma Equity Group (PEG) market capitalization is approximately DKK114.65M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Pharma Equity Group's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:43 PM Eastern Time
Pharma Equity Group (PEG) does not currently pay a dividend. Over the last twelve months (LTM), the company paid DKK0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future.
Based on the latest available analyst coverage, Pharma Equity Group (PEG) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: December 30, 2025 at 11:02 AM Eastern Time
Like other publicly traded stocks, Pharma Equity Group (PEG) shares are bought and sold on stock exchanges such as CPSE and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Pharma Equity Group (PEG) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.
At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add PEG to your watchlist.
Pharma Equity Group trades under the ticker symbol PEG on the CPSE stock exchange. The ticker PEG is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.
Pharma Equity Group (PEG) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Pharma Equity Group (PEG) stock peers based on overlapping products, services, and competitive dynamics:Financière de Tubize (TUB)Shandong Wohua Pharmaceutical (002107)Hunan Jingfeng Pharmaceutical (000908)Regent Pacific Group (575)Viatris (VTRS) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Pharma Equity Group.
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.